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Increasing evidence indicates that ion channels and transporters cooperate in regulating
different aspects of tumor pathophysiology. In cancer cells, H+/HCO3
- transporters usually
invert the transmembrane pH gradient typically observed in non-neoplastic cells, which is
thought to contribute to cancer malignancy. To what extent the pH-regulating
transporters are functionally linked to K+ channels, which are central regulators of cell
membrane potential (Vm), is unclear. We thus investigated in colorectal cancer cells the
implication of the pH-regulating transporters and KV11.1 (also known as hERG1) in the pH
modifications stimulated by integrin-dependent cell adhesion. Colorectal cancer cell lines
(HCT 116 and HT 29) were seeded onto b1 integrin-dependent substrates, collagen I and
fibronectin. This led to a transient cytoplasmic alkalinization, which peaked at 90 min of
incubation, lasted approximately 180 min, and was inhibited by antibodies blocking the b1
integrin. The effect was sensitive to amiloride (10 µM) and cariporide (5 µM), suggesting
that it was mainly caused by the activity of the Na+/H+ antiporter NHE1. Blocking KV11.1
with E4031 shows that channel activity contributed to modulate the b1 integrin-
dependent pHi increase. Interestingly, both NHE1 and KV11.1 modulated the colorectal
cancer cell motility triggered by b1 integrin-dependent adhesion. Finally, the b1 integrin
subunit, KV11.1 and NHE1 co-immunoprecipitated in colorectal cancer cells seeded onto
Collagen I, suggesting the formation of a macromolecular complex following integrin-
mediated adhesion. We conclude that the interaction between KV11.1, NHE1, and b1
integrin contributes to regulate colorectal cancer intracellular pH in relation to the tumor
microenvironment, suggesting novel pharmacological targets to counteract pro-invasive
and, hence, pro-metastatic behavior in colorectal cancer.
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Ion channels and transporters are progressively emerging as
pivotal modulators of different aspects of cancer cell behavior
(Arcangeli et al., 2009; Lastraioli et al., 2015a). Such pleiotropic
effects can be traced back to the regulation of either Vm (an effect
mainly exerted by K+ channels; Huang and Jan, 2014), or of the
concentration and intracellular distribution of specific ion
species, such as Ca2+ (Bose et al., 2015) and H+ (Gadsby,
2009), or to the direct modulation of intracellular signaling
pathways (Arcangeli et al., 2009; Becchetti et al., 2019).
However, the molecular interactions between these
mechanisms are poorly understood, and a unified picture of
the cancer cell pathophysiology is still missing.
One of the K+ channels most often dysregulated in cancer is
KV11.1 (orhERG1),which regulates the restingVm in excitable cells
(Bauer and Schwarz, 2018), as well as in cancers arising from
excitable (e.g. neuroblastomas, Crociani et al., 2003) and non-
excitable tissues. In particular, KV11.1 modulates intracellular
signaling pathways triggered by integrin-mediated adhesion, both
in leukemias (Pillozzi andArcangeli, 2009) andsolid cancers suchas
the colorectal (Crociani et al., 2013), pancreatic (Lastraioli et al.,
2015b), gastric (Crociani et al., 2014) and mammary (Becchetti
et al., 2017). The underlyingmechanism involves the formation of a
macromolecular complex between KV11.1 and b1-integrins, which
promotes angiogenesis and triggers metastatic spread (Crociani
et al., 2013; Becchetti et al., 2017). In pancreatic ductal
adenocarcinoma cells, this occurs through the regulation of f-
actin dynamics in filopodia (Manoli et al., 2019).
Cancer proliferation and migration are also controlled by
intracellular pH, whose regulation is frequently dysregulated in
tumors (Webb et al., 2011). Hence, targeting the pH regulating
transporters has been suggested as a therapeutic strategy (Persi
et al., 2018). Cancer cells generally display a higher activity of the
V-type H+-ATPases expressed on the plasmalemma (Sennoune
et al., 2004), the Na+/H+ exchanger NHE1 (Stock and Pedersen,
2017), the monocarboxylate transporters (MCTs) (Pinheiro
et al., 2012), the Na+/HCO3
- cotransporters (NBCs)
(Gorbatenko et al., 2014), and the membrane-associated
carbonic anhydrases (CAs), such as CA II and CA IX (Mboge
et al., 2018). The concerted activity of these proteins generally
leads to an inverted transmembrane pH gradient, characterized
by alkalization of intracellular pH (pHi) and extracellular
acidosis. This is considered a hallmark of cancer metabolism
(Sharma et al., 2015), being associated with increased tumor
proliferation, invasion, metastasis , and thus higher
aggressiveness and resistance to treatment (McCarty and
Whitaker, 2010). Both the pHi alkalinization and the
extracellular acidosis sustained by the higher activity of H+
transporters in cancer cells promote cell proliferation, escape
from apoptosis and metabolic adaptation (Webb et al., 2011). In
addition, the inverted pH gradient is involved in the control of
cell migration (Webb et al., 2011). An acid extracellular
environment favors the formation of invadopodia and activates
proteases that degrade the extracellular matrix, hence favoring
cancer cell motility and invasiveness (Busco et al., 2010).
Conversely, an alkaline pHi stimulates cell motility byFrontiers in Pharmacology | www.frontiersin.org 2promoting cytoskeleton assembly and focal adhesion
remodeling (Srivastava et al., 2008; Frantz et al., 2008), and
hence is one of the main hallmarks of metastatic tumors (Stock
and Schwab, 2009). In this scenario, a pivotal role is exerted by
integrin receptors and by the Na+/H+ antiporter NHE1, whose
reciprocal regulatory interaction was discovered in the late
eighties (Schwartz et al., 1989; Demaurex et al., 1996). In
particular, NHE1 is stimulated by cell adhesion, and in turn
regulates cell attachment and spreading onto fibronectin
(Harguindey et al., 2005; Stock and Schwab, 2006). In
migrating cells, the production of a pHi gradient along the axis
of movement accompanies the accumulation of NHE1 at the
migrating front, which localizes close to integrins (Grinstein
et al., 1993; Plopper et al., 1995; Ludwig et al., 2013). The acidic
pericellular environment at the leading edge is thought to
increase the pHe-dependent avidity of integrins, which
facilitates cell-matrix interactions and modulates adhesion
strength (Lehenkari and Horton, 1999; Eble and Tuckwell,
2003; Stock et al., 2005; Stock et al., 2008). The corresponding
local pHi increase stimulates the focal adhesion dynamics. First,
it supports the F-actin severing activity of cofilin (Frantz et al.,
2008), which produces free-barbed-end actin in the
lamellipodium. Second, it reduces the affinity of talin for actin
(Srivastava et al., 2008). It is thus clear that the pH regulating
mechanisms are essential determinants of the tumor
microenvironment and the cancer cell crosstalk.
Based on the above premises, we investigated whether the pH-
regulating transporters are functionally linked to KV11.1 channels,
which are strongly dysregulated in cancer cells, and whose activity
is tightly related to integrin receptors in modulating cancer cell
proliferation and migration (Becchetti et al., 2019). In particular,
we studied if pH regulating mechanisms provide a direct link
between integrin-mediated hERG1-dependent cell adhesion and
the tumor microenvironment. As a model, we used ColoRectal
Cancer (CRC) cells, in which knowledge about KV11.1 physiology
is particularly extensive.MATERIALS AND METHODS
Unless otherwise indicated, chemicals and drugs were purchased
from Sigma-Aldrich (St. Louis, USA).
Cell Lines and Cell Culture
The human colon carcinoma cell lines HCT 116 and HT 29 were
cultured at 37°C and 5% CO2 in air, in Roswell Park Memorial
Institute (RPMI) 1640 Medium, with sodium bicarbonate (2 g/L)
and 2mmol/L L-glutamine (“culture medium”), supplemented
with 10% fetal bovine serum (FBS) (Euroclone, Italy). In all
experiments, cells were starved overnight in culture medium
without serum (“no-serum medium”) and detached, prior to
experiment, with PBS plus 5 mM EDTA.
Coating of Culture Substrates
Extracellular Matrix (ECM) proteins at the final amount per cm2
of surface area shown in brackets: Fibronectin (FN, 5 mg),
Collagen-1 [Col-1, 10 mg; produced as reported in HallowesJune 2020 | Volume 11 | Article 848
Iorio et al. Kv11.1 and NHE1 in CRCet al. (1980)], Vitronectin [VN, 0.5 mg; produced as reported in
Yatohgo et al. (1988)]. Coating with Polylysine (PL, 0.1 µg) was
taken as a control of integrin-independent adhesion, while
seeding onto uncoated dishes was our “no-adhesion” control.
FN and VN were diluted in PBS, Col-1 in serum-free media, PL
in bi-distilled water and plated to cover the entire growth surface,
followed by 1 h incubation at either 37°C (for Col-1) or room
temperature (for FN, VN and PL). After the coating procedure,
incubation with Bovine Serum Albumin (BSA) for 15 min at 37°
C was performed to block all the uncovered plastic sites.
Measurement of pHi
To determine pHi, we used 2′,7′-Bis (2-carboxyethyl)-5 (6)-
carboxyfluorescein acetoxymethyl esther (BCECF-AM). Cells
were starved and detached as described above, and seeded (5 x
104 cells/well) in no-serummedium onto uncoated or coated (see
above) 96-well plates (clear bottom 96-well plate, polystyrene,
TC-treated, clear flat bottom wells, sterile, w/lid, black; Corning,
New York, USA). Cells were then incubated at 37°C in 5% CO2
for different times, in the absence or presence of different drugs
(see below). At selected time points, the medium was removed
and BCECF-AM (1mM final concentration in loading solution
(HBSS 1X plus 0.01% NaHCO3, pH 7)) was added for 30 min at
37°C and 5% CO2. After incubation, cells were washed twice with
loading solution at room temperature. For measurement of
initial (time 0) pHi, cells were detached, kept in suspension in
a 1.5 ml tube and incubated in BCECF-AM-containing solution
for 30 min at 37°C. Next, they were washed twice with loading
solution, poured in a 96-well plate at 5x104 cells/well at room
temperature, and immediately transferred to the microplate
reader. Fluorescence intensity was immediately measured with
a microplate reader (Infinite 200 PRO, Tecan, Switzerland) set at
the following wavelengths: 440–490nm for excitation and 535
nm for emission. A calibration curve was set up using a high K+/
Nigericin solution (135 mM KCl, 2 mM K2HPO4, 20 mM
HEPES, 1.2 mM CaCl2 and 0.8 mM MgSO4), in a range of pH
from 5.0 to 8.5. All pH values were calculated using 490/440nm
fluorescence ratio and applying standard curve and linear
equations, as detailed in Grant and Acosta, 1997.
Modulators of b1 Integrin-Mediated
Adhesion
The mouse monoclonal anti-b1 integrin antibody BV7 (anti-b1
Ab, kindly gifted by Prof. P. Defilippi, University of Turin, Italy)
(Martìn-Padura et al., 1994) was used to block b1-integrins as
described in Hofmann et al. (2001). Briefly, cells were seededFrontiers in Pharmacology | www.frontiersin.org 3onto Col-I in no serum medium, containing anti-b1 Ab (20 mg/
ml), for 90 min at 37°C and 5% CO2. Cells (mostly detached)
were collected, and pHi mesaurement was performed as above
described for time zero condition.
Modulators of pH-Regulating Transporters
and KV11.1
We used the following compounds: 100 µM acetazolamide (CA
inhibitor; Parkkila et al., 2000), 10 µM amiloride (inhibitor of
NHE1 and epithelial Na+ channel, ENaC; Masereel et al., 2003), 5
µM cariporide (specific NHE1 inhibitor; Hulikova et al., 2013),
30 µM S0859 (NBC inhibitor; Hulikova et al., 2013), and 40 µM
E4031 (Tocris, Bristol, UK; KV11.1 blocker; Masi et al., 2005),
Drugs were added to the cells seeded on uncoated or coated
surfaces at different time points. Preliminarily, all compounds
were tested for their potential cytotoxic effects at all the used
concentrations, by measuring cell viability with the trypan blue
test (Pillozzi et al., 2018), at 30, 90 and 180 min of incubation.
None of the modulators had any cytotoxic effect (Table 1).
Lateral Motility Assay
Lateral motility was determined using 35 mm dishes and
drawing 15 horizontal lines and 3 perpendicular lines on the
dish bottom to generate a grid system. Plates were coated with
Col-I and 5x105 cells were seeded and allowed to attach for 90
min. Three wounds were drawn following the 3 horizontal lines.
Subsequently, the following treatments were performed with
drugs diluted in RPMI medium: control, E4031 40 µM, E4031
40 µM + cariporide 5 µM. Then, the distances between cells were
measured at each mark point (where the 3 horizontal lines
crossed the 15 vertical lines) using a light microscope. The
widths measured at time 0 correspond to the W0 parameter.
These different 45 points were measured again after 90′. Motility
Index (MI) was assessed using the following formula: MI = 1 –
Wt/W0, where Wt is the width of the wounds after 90′.
Each treatment was performed in triplicate and the
experiments were carried out at least 3 times.
Co-Immunoprecipitation Experiments
For (co)-immunoprecipitation experiments cells were seeded
and incubated on Col-I. Cells were gently collected by mild
scraping and resuspended in ice cold PBS. Protein extraction,
quantification and total lysate incubation with protein A/G
agarose beads (Santa Cruz Biotechnology, Texas, USA) were
performed as previously reported (Becchetti et al., 2017). In
particular, the composition of the lysis buffer was the following:TABLE 1 | Percentage of alive cells after ICT modulators treatment for 30, 90, and 180 min (± s.e.m).
30′ 90′ 180′
HCT 116 HT 29 HCT 116 HT 29 HCT 116 HT 29
Acetazolamide 99.01 ± 0.004 99.02 ± 0.004 98.02 ± 0.003 99.01 ± 0.009 97.02 ± 0.004 96.03 ± 0.004
Amiloride 99.02. ± 0.002 98.01 ± 0.008 99.03 ± 0.002 99.01 ± 0.002 98.02 ± 0.002 98.01 ± 0.004
Cariporide 98.01 ± 0.001 98.02 ± 0.001 99.01 ± 0.001 98.01 ± 0.001 98.03 ± 0.015 98.01 ± 0.001
S0859 99.02 ± 0.004 99.01 ± 0.004 98.01 ± 0.003 99.03 ± 0.009 97.01 ± 0.004 96.02 ± 0.004
E4031 99.01 ± 0.005 99.04 ± 0.003 99.01 ± 0.004 99.02 ± 0.005 99.01 ± 0.005 99.03 ± 0.007June 2020 | Volume 11 | Article 848
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EDTA pH 8 (5 mM), NaF (10 mM), Na4P2O7 (10 mM), Na3VO4
(0.4 mM), and protease inhibitor cocktail (cOmplete Mini-
Roche, Germany).
The following antibodies were used at the concentration of 5µg
per mg of extracted proteins: LEAF Purified anti-human, Clone
TS2/16 (BioLegend, California, USA) to immunoprecipitate the
b1-integrin; mAb KV11.1 (MCK Therapeutics, Italy) to
immunoprecipitate KV11.1. After overnight incubation, the
immuno-complex was captured by adding 30 µl of protein A/G
agarose beads for 2 h at 4°C (with rolling agitation). The agarose
beads were washed 3 times in ice-cold wash buffer and 3 times in
ice cold PBS followed by addition of 2X Laemli buffer (10 µl) and
boiled for 5 min at 95°C. Afterwards, SDS-PAGE was performed.
After electrophoresis, proteins were transferred onto PVDF
membrane (previously activated) in blotting buffer under cold
condition for 1 h at 100 V. The PVDF membrane was then
blocked with 5% BSA in T-PBS (0.1% tween) solution for 3h at
room temperature to cover the unspecific antibody binding sites
on the membrane. SDS-PAGE and antibody incubation were
performed as previously described (Becchetti et al., 2017). The
following antibodies were used: anti b1-integrin, RM-12,
polyclonal rabbit antibody, dilution 1:1,000 (Immunological
Science, Italy); anti-Kv11.1, C54 polyclonal rabbit antibody,
dilution 1:1,000 (DI.V.A.L TOSCANA S.R.L., Italy); anti-NHE1
polyclonal rabbit antibody, dilution 1:500 (Novus Biologicals,
Colorado, USA) and anti-tubulin, monoclonal mouse, dilution
1:500 (Santa Cruz Biotechnology, Texas, USA). The following day
the membrane was washed with T-PBS (0.1% tween) (15 min x 3
times) and appropriate secondary antibody: (i) conjugated with
peroxidase enzyme was dissolved in 5% BSA in T-PBS (0.1%
tween) (dilution 1:10.000) for at least 45 min and washed (15 min
x 3 times), revealing was performed using ECL solution in dark
room (anti-C54 primary antibody) and (ii) for all other primary
antibodies, IRDYe 800 CW (LI-COR Biosciences, Nebraska, USA)
was dissolved in 5% BSA in T-PBS (0.1% tween) (dilution
1:20.000) for at least 45 min and washed (15 min x 3 times)
before membrane scanning using LI-COR Odyssey Scanner
(Biosciences, Nebraska, USA).Protein Quantification
Data were analyzed with ImageJ and graphs were plotted with
OriginPro8. When quantifying variations in KV11.1-b1 integrin
interaction, the signal for co-immunoprecipitated protein was first
divided by the signal of the protein used for immunoprecipitation
and then normalized to the signal of the corresponding protein in
the total lysate.Statistical Analysis
OriginPro8 was used for analysis. Data groups were tested for
normality (Shapiro-Wilk test) and variance homogeneity (Welch
test). Statistical significance for two sample analysis was carried
out with unpaired t-test. Multiple comparisons were carried out
by One-way ANOVA, with post-hoc Bonferroni test. A p value ≤
0.05 was considered statistically significant.Frontiers in Pharmacology | www.frontiersin.org 4RESULTS
Cell Adhesion Mediated by b1 Integrin
Produces an Early pHi Alkalinization in
HCT 116 and HT 29 CRC Cells
HCT 116 and HT 29 cells were incubated in serum-free medium
for different times (0–180 min) onto different ECM substrates:
Col-I, FN, and VN. Polylysine or no-coated plastic surfaces were
used as integrin-independent or “no-adhesion” controls,
respectively. At different time points, pHi was determined by
BCECF-AM. Although with slightly different time courses, both
cell lines underwent an early pHi increase between 0 and 90 min
(Figures 1A, B). At 90 min of incubation, pHi was significantly
higher in cells seeded onto Col-I and FN, i.e., two substrates
recognized by b1 integrins, which are well expressed in both cell
lines (Table 2). Indeed, treatment with a b1 integrin blocking
antibody (BV/, Martìn-Padura et al., 1994) (indicated as “anti-b1
Ab” in Figure 1) not only blocked cell adhesion (panel A’ and
B’), but also prevented the pHi increase triggered by cell adhesion
onto Col-I. In particular, pHi increased from 6.7 at time 0 (i.e.,
before seeding) to 7.2 at 90 min in cells seeded either onto Col-I
or FN. In contrast, pHi remained close to the time 0 value (6.74
±0.006 for HCT 116 and 6.66±0.014 for HT 29) in CRC cells
seeded onto Col-I and treated with the anti-b1 Ab (insets to
Figures 1A, B). The pHi alkalinization was much smaller in cells
seeded onto VN (in agreement with the very low expression of
b3-integrins in both cell lines, see Table 2), or polylysine or no-
coating conditions. Subsequently (i.e., after 90 min of
incubation), the pHi observed in cells seeded on Col-I and FN
progressively returned to the control value. At 180 min, cells
displayed a pHi around 7.0, irrespective of growing conditions
(Figures 1A, B). Such values were maintained for at least 24 h
(the complete data set is given in Table 3). We conclude that the
b1 integrin-mediated adhesion triggers an early and transient
pHi alkalinization from 6.7 to 7.2 in CRC cells.
The pHi Variations Triggered by b1
Integrin-Dependent Adhesion in CRC Cells
Depend on NHE1 Activation and Are
Modulated by KV11.1 Activity
To better determine the mechanism of integrin-dependent pHi
increase, we applied blockers of the different pH-regulating
transporters expressed in CRC cells (Table 2). In particular, we
tested acetazolamide (a wide CA inhibitor), amiloride (an NHE
blocker, in particular of NHE1, as well as of ENaC), cariporide (a
specific NHE1 inhibitor), and S0859 (an inhibitor of all NBCs).
Drugs were used at the concentrations indicated in Materials and
Methods, on cells seeded onto Col-I for 90 min, since the
beginning of the experiment. Acetazolamide had no effect on
pHi of either cell line, whereas both amiloride and cariporide
produced a statistically significant decrease of pHi which reached
values comparable to those detected in cells before seeding
(dotted line in Figure 2). The same effect was produced by
cariporide. The treatment with S0859 produced a reduction of
pHi, although much lower compared to that obtained with
amiloride (Figures 2A, B).June 2020 | Volume 11 | Article 848
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b1 integrin-mediated adhesion is mostly sustained by the activity
of the Na+/H+ antiporter NHE1, with a lesser contribution of
NBC, and scarse involvement of carbonic anhydrases.
We then tested whether KV11.1 was involved in the integrin-
dependent pHi alkalinization. To this purpose, cells were treatedFrontiers in Pharmacology | www.frontiersin.org 5with the KV11.1 blocker E4031, at 40 µM (Masi et al., 2005).
After 90 min of cell adhesion on Col-I, both HCT 116 and HT 29
cells treated with E4031 showed pHi values significantly more
acidic compared to the untreated controls (Figures 2A, B).
Hence, the activity of KV11.1 appears to control NHE1
activation, after b1 integrin-mediated adhesion. ThisA A'
B B'
FIGURE 1 | Effect of Collagen I, Fibronectin, and Vitronectin on pHi in HCT 116 and HT 29 cells. The time course of pHi is reported in panel (A) (HCT 116) and in
panel (B) (HT 29). Simbol ▪: No coating surface, •: PL coating, ▲: Col-I coating, ▼: FN coating, ♦: VN coating, ○: Col-I anti-b1 Ab. On the right of the panel, 90 min
pHi values are reported. Light grey bar: No coating surface, dark grey bar: Col-I, black bar: FN and striped bar: Col-I anti-b1 Ab. Number represent mean ± s.e.m (of
three different experiments). *, P < 0.05; **, P < 0.01 and ***, P < 0.001. p value after 30 min of seeding, panel (A): ***P < 0.001: Col-I vs Control: 0.0005, FN vs
Control: 0.0005; p value after 90 min of seeding, panel (A): ***P < 0.001: Col-I vs Control: 0.0001, FN vs Control: 0.0001; *P < 0.05: No coat vs Control: 0.01, PL vs
Control: 0.01 and VN vs Control: 0.02. p value after 180 min of seeding, panel (A): *P < 0.05: No coat vs Control: 0.01, PL vs Control: 0.01 and VN vs Control:
0.01, Col-I vs Control: 0.01, FN vs Control: 0.01. p value after 30 min of seeding, panel (B) ***P < 0.001: Col-I vs Control: 0.0001 and FN vs Control: 0.0001; p
value after 90 min of seeding, panel (B) ***P < 0.001: Col-I vs Control: 0.0001 and FN vs Control: 0.0001; *P < 0.05: No coat vs Control: 0.01, PL vs Control: 0.01
and VN vs Control: 0.01. p value after 180 min of seeding, panel (B) *P < 0.05: No coat vs Control: 0.01, PL vs Control: 0.01, VN vs Control: 0.01, Col-I vs Control:
0.01 and FN vs Control: 0.01. p value after 30 min of seeding, panel (A): ***P < 0.001: Col-I vs No coat: 0.001 and FN vs No coat: 0.001. p value after 90 min of
seeding, panel (A): Col-I vs No coat: 0.0001, FN vs No coat: 0.0001; Col-I anti-b1 Ab vs Col-I: 0.0007; Col-I anti-b1 Ab vs FN: 0.0006. p value after 30 min of
seeding, panel (B) ***P < 0.001: Col-I vs No coat: 0.001 and FN vs No coat: 0.001. p value after 90 min of seeding, panel (B) Col-I vs No coat: 0.001 and FN vs No
coat: 0.001. Col-I anti-b1 Ab vs Col-I: 0.0006; Col-I anti-b1 Ab vs FN: 0.0005. Representative images of cells seeded for 90 min on Col-I, no treated and treated
with anti-b1 Ab are reported in panels AI (HCT 116) and BI (HT 29), 100 µm scale bar. The conditions are shown on the top of each picture. Cells seeded on Col-I
are elongated and attached, cells seeded on Col-I and treated with anti-b1 Ab are round and detached.TABLE 2 | Integrin profile and ICT expression of HCT 116 and HT 29 cell lines.
HCT 116 HT 29
a1b1(Col-I), a2b1(Col-I) + (Boudjadi et al., 2016; Gout et al., 2001) + (Boudjadi et al., 2016; Pelillo et al., 2015)
a3b1(FN), a4b1(FN) + (Pelillo et al., 2015; Ito et al., 2004) + (Gout et al., 2001; Ito et al., 2004)
a5b1(FN) + (Pelillo et al., 2015) - (Schmidt et al., 1998)
a8b1(FN) - (Benoit et al., 2010) - (Benoit et al., 2010)
aVb3(FN), aVb3(VN) - (Pelillo et al., 2015) - (Christenheit et al., 2016)
aVb6(FN) + (Kim et al., 2018) + (Kim et al., 2018)
Kv 11.1 + (Pillozzi et al., 2018) + (Pillozzi et al., 2018)
CA IX - (McIntyre et al., 2012) + (McIntyre et al., 2012)
NHE1 + (Hulikova et al., 2011) + (Hulikova et al., 2011)
NBCe1 + (Hulikova et al., 2011) + (Hulikova et al., 2011)
MCT1 + (Jin et al., 2019) + (Jin et al., 2019)
MCT4 + (Choi et al., 2019) + (Choi et al., 2019)June 2020 | Volume 11 | Article 848
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B
FIGURE 2 | Effect of Acetazolamide, Amiloride, S0859, Cariporide, E4031, and E4031 plus Cariporide on pHi in cells seeded on collagen I, 90 min treatment, in
HCT 116 and HT 29 cells. pHi values of HCT 116 are reported in panel (A) and for HT 29 in panel (B). Red line: pHi value at time zero. Number represent mean ±
s.e.m (of three different experiments). *, P < 0.05 and ***, P < 0.001. p value panel (A): ***P < 0.001: Control vs Amil: 1.9e^-05, Control vs Carip: 1.9e^-05, Control vs
E4031: 0.0001, Control vs E4031+Carip: 1.8e^-05Acet vs Carip: 1.7e^-05; *P < 0.05: Control vs S0859: 0.03, Acet vs S0859: 0.03, Amil vs S0859: 0.02; Carip vs
S0859: 0.02; S0859 vs E4031+ Carip: 0.02. p value panel (B): ***P < 0.001: Control vs Amil: 1.5e^-05, Control vs Carip: 1.4e^-05, Acet vs Carip: 1.3e^-05; Control vs
E4031: 0.0001 and Control vs E4031+Carip: 1.9e^-05; *P < 0.05: Control vs S0859: 0.04, Acet vs S0859: 0.03; S0859 vs E4031+ Carip: 0.02.TABLE 3 | Complete set of raw pHi values.
HCT 116 0’ 30’ 90’ 180’ 360’ 1440
No Coating 6.70 ± 0.008 6.82 ± 0.005 6.96 ± 0.045 7.00 ± 0.003 7.10 ± 0.004 7.12 ± 0.013
Polylysine 6.70 ± 0.008 6.75 ± 0.036 7.03 ± 0.011 7.02 ± 0.012 7.12 ± 0.013 7.12 ± 0.012
Collagen I 6.70 ± 0.008 7.15 ± 0.009 7.26 ± 0.007 7.01 ± 0.005 7.11 ± 0.008 7.01 ± 0.015
Fibronectin 6.70 ± 0.008 7.16 ± 0.023 7.29 ± 0.026 7.08 ± 0.004 7.05 ± 0.014 7.18 ± 0.04
Vitronectin 6.70 ± 0.008 6.77 ± 0.011 6.98 ± 0.016 6.99 ± 0.045 7.00 ± 0.025 7.10 ± 0.015
HT 29 0’ 30’ 90’ 180’ 360’ 1440
No Coating 6.65 ± 0.014 6.81±0.035 7.00 ± 0.021 6.99 ± 0.01 7.09 ± 0.01 7.09 ± 0.01
Polylysine 6.65 ± 0.014 6.84 ± 0.096 6.99 ± 0.006 7.12 ± 0.02 7.16 ± 0.001 7.16 ± 0.001
Collagen I 6.65 ± 0.014 7.22 ± 0.037 7.21 ± 0.005 7.03 ± 0.027 7.11 ± 0.023 7.11 ± 0.023
Fibronectin 6.65 ± 0.014 7.21 ± 0.042 7.26 ± 0.024 6.98 ± 0.006 7.03 ± 0.028 7.03 ± 0.028
Vitronectin 6.65 ± 0.014 6.84 ± 0.037 6.98 ± 0.027 6.99 ± 0.011 7.01 ± 0.017 7.01 ± 0.017Frontiers in Pharmacology | www.frontiersin.org 6 June 2020 | Volume 11 | Article 848
Iorio et al. Kv11.1 and NHE1 in CRCinterpretation was supported by the observation that the
combined treatment with E4031 and cariporide had no further
effect on the pHi value obtained after NHE1 inhibition by
cariporide (Figures 2A, B).
Blockade of Either NHE1 or KV11.1 Inhibits
Lateral Motility of CRC Cells
Next, based on the known correlation between pHi and cell
motility, we performed experiments of lateral motility on our
CRC cell lines, which were seeded onto Col-I for 90 min, and
treated with either E4031, or cariporide, or a combination of
both. Both cariporide and E4031 produced a statistically
significant reduction of the motility index compared to
untreated cells (Figures 3A, B). The combined treatment with
E4031 and cariporide only slightly increased the inhibitory
effects of the single treatments on the motility index of either
cell line. We conclude that both KV11.1 and NHE1 are involved
in controlling the b1 integrin-dependent cell motility in
CRC cells.
b1-Integrin, KV11.1, and NHE1 Form a
Macromolecular Complex
We previously showed that cell adhesion onto b1 integrin-
dependent substrates (e.g., FN or Col-I), induces KV11.1
activation, as well as the formation of a macromolecular
signaling complex between the channel and b1 integrin on the
plasma membrane of HCT 116 cells (Crociani et al., 2013). We
thus hypothesized that NHE1 could be also recruited in such
complex, which could account for the functional cross-talk
between integrin receptors, KV11.1, and NHE1 in CRC cells.
Hence, we seeded HCT116 cells on either uncoated or Col-I-
coated surfaces for 90 min, and immunoprecipitated theFrontiers in Pharmacology | www.frontiersin.org 7extracted proteins with anti-b1 integrin or anti-KV11.1
antibodies. Blots were then revealed, respectively, with anti-
KV11.1 or anti-b1 integrin antibodies, as well as with anti-
NHE1 antibodies. We observed that b1-integrin co-
immunoprecipitated with both KV11.1 and NHE1 in CRC cells
before cell seeding (“pre seeding” in Figure 4), indicating the
formation of a b1/Kv11.1/NHE1 complex, whose assembly was
further promoted by cell adhesion onto Col-I for 90 min (lanes 3
and 4 in Figure 4). On the contrary, in cells seeded onto
uncoated surfaces, only a weak co-immunoprecipitation was
observed between b1-integrin and KV11.1, and no association
was observed with NHE1. We conclude that cell adhesion onto
Col-I stimulates the formation of a macromolecular complex
between b1-integrin, KV11.1, and NHE1.DISCUSSION
In the present paper, we provide evidence that, in CRC cells, the
b1 integrin-mediated adhesion onto ECM proteins such as Col-I
and FN triggers an early and transient pHi alkalinization, from
6.7 to 7.2. The effect is caused by NHE1 activation and is
modulated by the activity of the voltage-dependent K+ channel
KV11.1. The transporter and the channel appear to cooperate in
sustaining the ECM-induced CRC cell motility. Their action is
accompanied by the formation of a macromolecular complex
between the b1 integrin, KV11.1 and NHE1.
The rapid b1 integrin-dependent pHi alkalinization in CRC
cells is similar to the one initially reported in bovine capillary
endothelial cells (Schwartz et al., 1991), which is also induced by
integrin engagement (mainly b1), and sustained by activation of
the Na+/H+ exchanger. In our model, we confirmed the NHE1A B
C
D
FIGURE 3 | Effect of E4031 and E4031 plus Cariporide on motility index in cells seeded on col-I, 90 min treatment. Motility index values are reported for HCT 116 in
panel (A) and for HT 29 in panel C. Number represent mean ± s.e.m (of three different experiments). Representative images are reported in panel (B) for HCT 116
and in panel (D) for HT 29, 200 µm scale bar. In figure the statistically significant differences between control and treatments are reported. **, P < 0.01. p value panel
(A): **, P < 0.01: Control vs E4031: 0.002 and Control vs E4031+Carip: 0.001. p value panel (C): **, P < 0.01: Control vs E4031: 0.003 and Control vs E4031
+Carip: 0.001.June 2020 | Volume 11 | Article 848
Iorio et al. Kv11.1 and NHE1 in CRCinvolvement by showing that ECM-dependent alkalinization was
blocked by cariporide.
Following Schwartz’s seminal observation, the pH regulatory
role of NHE1 in normal and cancer cells has been receiving
increasing attention (Stock and Pedersen, 2017). In particular, in
CRC cells, both H+ extrusion through NHE1 and HCO3
- influx
through NBCe1 give a significant contribution to pHi regulation.
However, while HCO3
- influx appears to represent a constitutive
element of pHi regulation, the NHE1-mediated H
+ efflux may
vary, depending on culture conditions, e.g. 2D vs 3D cultures
(Hulikova et al., 2011). In CRC cells, we found that the Na+/
HCO3
- cotransporter, although present, provides only a weak
contribution to the integrin-dependent alkalinization in CRC
cells. In fact, NHE1 appears to constitute the main molecular
device linking the ECM microenvironment to pHi regulation.
Numerous mechanisms leading to NHE1 activation have
been described in the various cell types in which the
transporter is expressed (Orlowski and Grinstein, 2004).
Stimuli such as growth factors, peptide hormones etc., which
activate receptor tyrosine kinases and G protein-coupled
receptors, enhance NHE1 activity, through the involvement of
the mitogen-activated, extracellular signal-related kinase (MEK-
ERK)-p90rsk. The latter phosphorylates NHE1, and enables its
binding to the multifunctional scaffolding protein 14-3-3, which
in turn serves as a hub for the assembly of other signaling
molecules which eventually enhance cation exchange (Orlowski
and Grinstein, 2004). In this scenario, it is not surprising that
integrins exert a stimulatory role on NHE1, as they are known to
trigger intracellular signaling pathways that can lead to NHE1
activation (Putney et al., 2002). Integrins, and the tumorFrontiers in Pharmacology | www.frontiersin.org 8microenviroment as a whole, can contribute to trigger a
complex signaling pathway which in turn regulates NHE1-
dependent motility and invasion in different cancer cells
(Cardone et al., 2005). In particular, NHE1 is linked to the
actin cytoskeleton and integrates phosphorylation signals arising
from kinases which are involved in cytoskeletal reorganization
and cell motility. In addition, NHE1 is preferentially localized in
pseudopodia, focal adhesion plates, and invadopodia in
migrating cells (Paradiso et al., 2004; Patel and Barber, 2005;
Clement et al., 2013). In this context, a slight alkalinization
mediated by NHE1 was found to regulate the cofilin-mediated
actin assembly (Frantz et al., 2008), a central mechanism in cell
protrusion. Hence, NHE1 and cofilin respectively act as a pH
regulator and a pH sensor, to mediate actin filament assembly.
The most novel result emerging from our data is that the
KV11.1 channel is implicated in the pHi alkalinization triggered
by integrin-mediated cell adhesion to ECM proteins, and
sustained by NHE1 activity. KV11.1 is over-expressed in many
cancer types, including CRC (Lastraioli et al., 2004; Lastraioli
et al., 2012; Crociani et al., 2013; Iorio et al., 2020). In cancers, b1
integrin-mediated adhesion to FN or Col-I activates KV11.1, and
induces the formation of a macromolecular functional complex
on the plasma membrane which comprises the channel and the
integrin itself. This occurs preferentially when the channel is in
the closed conformation, and leads to the activation of signaling
pathways, which also involve the scaffold protein 14-3-3, and in
turn control different aspects of cancer cell behavior (Becchetti
et al., 2017; Becchetti et al., 2019). The recruitment of NHE1 in
the KV11.1/b1 integrin complex could give rise to the formation
of a signaling hub, facilitating NHE1 activation and hence aA B 
FIGURE 4 | b1-integrin, KV11.1, and NHE1 protein complex. (A) Co-immunoprecipitation of b1 Integrin, Kv 11.1 and NHE1 in HCT 116 cells, seeded on no coating
surface and Col-I for 90 min. Densitometric analysis is reported in panel (A). In panel A with “WB” is indicated the protein signal in the co-ip and with “INPUT” the
protein signal in the total lysate. Pre-seeding condition is reported as pre, No coating as No coat and Collagen I as Col-I; The immunoprecipitation with anti b1
integrin antibody is indicated as IP b1 and with anti KV11.1 antibody is reported as IP KV11.1. Complex quantification is reported in panel B, black bar: b1-integrin,
KV11.1 and NHE1 protein complex and white bar: b1-integrin and KV11.1 protein complex. Number represent mean ± s.e.m (of three different experiments). **, P <
0.01 and ***, P < 0.001. p value panel (B), ***, P < 0.001: b1-integrin/KV11.1/NHE1 complex, Pre vs Col-I IP b1, p: 0.0008; b1-integrin/KV11.1 complex, Pre vs Col-I
IP b1, p: 0.00075; b1-integrin/KV11.1/NHE1 complex, Pre vs Col-I IP KV11.1, p: 0.00076; b1-integrin/KV11.1 complex, Pre vs Col-I IP KV11.1 p: 0.00074. b1-
integrin/KV11.1/NHE1 complex, No coat vs Col-I IP b1, p: 1.7e^-05; b1-integrin/KV11.1 complex No coat vs Col-I IP b1, p: 0.00072; b1-integrin/KV11.1/NHE1
complex, No coat vs Col-I IP KV11.1, p: 1.9e
^-05; b1-integrin/KV11.1 complex, No coat vs Col-I IP KV11.1, p: 0.00073. **, P < 0.01: b1-integrin/KV11.1/NHE1
complex, Pre vs No coat: 0.002; b1-integrin/KV11.1/NHE1 complex vs b1-integrin/KV11.1 complex, No coat IP b1: 0.002. Cropped images of blots are reported.June 2020 | Volume 11 | Article 848
Iorio et al. Kv11.1 and NHE1 in CRClocalized pHi alkalinization, which in turn could affect the
reorganization of actin filaments, presumably regulated by
cofilin activation. This agrees with our recent observations in
pancreatic ductal adenocarcinoma cells, where KV11.1 regulates
cell migration through a reorganization of f-actin in stress fibers
and a modulation of filopodia formation and dynamics (Manoli
et al., 2019).
The identification of the signaling mechanisms underlying
KV11.1 and NHE1 interaction triggered by b1 integrin–mediated
adhesion needs further experiments. Nevertheless, the interplay
between a K+ channel and the pH regulating transporter NHE1
that we describe in the present paper can be considered of
relevance in the context of CRC invasiveness/motility. This
aspect is often dependent on a complex interaction between
cancer cells and the tumor microenvironment, and in particular
with ECM proteins like collagens and fibronectin (Arcangeli,
2011). Finally, targeting the integrin/ion channel/NHE1
molecular hub might represent a therapeutic option to fight
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